Ouabain induces apoptotic cell death in type I spiral ganglion neurons, but not type II neurons.
Application of ouabain to the intact round-window (RW) membrane of the gerbil cochlea induces apoptosis in most spiral ganglion neurons (SGNs), leaving a few neurons intact (Schmiedt et al. 2002). Here, physiological measures and immunostaining were used to examine the process of SGN degeneration at 3, 6, 12, and 24 h, 4 days, and 1 and 5 months after ouabain treatment. The few remaining neurons surviving up to 5 months after ouabain treatment were immunoreactive for peripherin, a type II neuron marker. Peripherin-positive cell counts indicate that about 7% of the SGNs in the gerbil cochlea are type II neurons, and these neurons survive intact after ouabain treatment. Ouabain exposure had little effect on the outer hair cell and lateral wall systems, even after a 5 month loss of auditory-nerve function. The cellular locations of cytochrome c, poly (ADP-ribose) polymerase (PARP), and activated caspase 3 were examined in control and ouabain-treated cochleas. A redistribution of cytochrome c in peripherin-negative (type I) neurons was observed at 3 h after ouabain exposure. Degraded PARP and activated caspase 3 were also detected in peripherin-negative SGNs at 6 and 24 h after treatment, respectively. These results suggest that the redistribution of cytochrome c is an early event during apoptosis in type I SGNs and that activation of PARP and caspase 3 are associated with apoptosis in these cells. Calcineurin and NF-kappaB are two important signaling pathways that may modulate cell survival in the central nervous system. Here, we found that calcineurin and NF-kappaB selectively labeled type II neurons. It is speculated that the high levels of calcineurin and NF-kappaB in type II SGNs, as compared with type I SGNs, may play protective roles in enhancing the survival of type II neurons exposed to ouabain.
Lang
H
H
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. langh@musc.edu
Schulte
B A
BA
Schmiedt
R A
RA
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001309:Auditory Threshold / Q000187:drug effects; D019703:Calcineurin / Q000378:metabolism; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D003051:Cochlea / Q000187:drug effects / Q000473:pathology; D024161:Collagen Type XI / Q000378:metabolism; D045304:Cytochromes c / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005260:Female; D005849:Gerbillinae; D008297:Male; D016328:NF-kappa B / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010042:Ouabain / Q000494:pharmacology*; D013136:Spiral Ganglion / Q000187:drug effects* / Q000473:pathology*; D051996:Transcription Factor RelA
D024161:Collagen Type XI; D004791:Enzyme Inhibitors; D016328:NF-kappa B; D051996:Transcription Factor RelA; D010042:Ouabain; D045304:Cytochromes c; D019703:Calcineurin; D053148:Caspase 3; D020169:Caspases
Methods Cell Biol. 1995;46:1-27
7609651
Science. 2002 Jul 12;297(5579):200-1
12114611
J Assoc Res Otolaryngol. 2003 Jun;4(2):164-75
12943371
Brain Res. 1986 Sep 24;383(1-2):327-32
3533212
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9574-8
2556718
J Assoc Res Otolaryngol. 2002 Sep;3(3):223-33
12382099
Genes Dev. 1995 Nov 15;9(22):2723-35
7590248
Neurobiol Dis. 2000 Aug;7(4):225-39
10964595
J Neurochem. 1992 May;58(5):1798-809
1313854
Acta Otolaryngol. 1975 Mar-Apr;79(3-4):266-75
1094788
Mol Cell Biol. 2003 Apr;23(8):2680-98
12665571
Ann Otol Rhinol Laryngol Suppl. 1984 Jul-Aug;112:76-82
6431887
J Neurotrauma. 2000 Oct;17(10):843-55
11063052
Acta Otolaryngol. 1969 Feb-Mar;67(2):239-54
5374642
Brain Res. 1999 Nov 20;847(2):357-9
10575109
Science. 1982 Jul 9;217(4555):175-7
7089553
Ann Otol Rhinol Laryngol. 1976 Nov-Dec;85(6 PT. 1):752-68
999140
Neuroscience. 1997 Jun;78(3):673-84
9153650
Ann N Y Acad Sci. 2003 Jun;991:111-9
12846980
J Comp Neurol. 1979 Dec 1;188(3):429-442
489802
Hear Res. 2000 Mar;141(1-2):12-8
10713491
Ann Otol Rhinol Laryngol. 1976 Nov-Dec;85(6 PT. 1):740-51
999139
J Neurosci. 1999 Oct 15;19(20):8856-65
10516305
Neurobiol Dis. 2003 Dec;14(3):303-17
14678748
J Neurocytol. 1997 Aug;26(8):541-56
9350806
Nature. 1994 Sep 22;371(6495):346-7
8090205
Nature. 1993 Jan 7;361(6407):31-9
8421494
Ann N Y Acad Sci. 2003 May;993:217-28; discussion 287-8
12853316
Brain Res. 1986 Nov 5;397(1):161-72
3542117
J Neurosci. 2002 Feb 15;22(4):1350-62
11850462
Biochemistry. 1980 Apr 29;19(9):1831-7
6246935
Neuron. 2002 Feb 28;33(5):751-63
11879652
Hear Res. 1996 May;94(1-2):148-56
8789820
Proc Natl Acad Sci U S A. 1987 Feb;84(4):1118-22
3029762
Hear Res. 1995 Oct;90(1-2):192-201
8974997
Neuroscience. 1992 Aug;49(3):545-56
1323805
J Assoc Res Otolaryngol. 2003 Dec;4(4):466-77
14534835
J Histochem Cytochem. 2001 Feb;49(2):187-95
11156687
Cell. 1997 Nov 28;91(5):559-62
9393848
Hear Res. 1988 Apr;33(1):11-33
3372368
Nature. 1994 Jun 9;369(6480):486-8
7515479
J Acoust Soc Am. 1996 Nov;100(5):3275-85
8914310
J Comp Neurol. 2000 Feb 7;417(2):205-20
10660898
Arch Otolaryngol. 1978 Feb;104(2):84-8
629704
Arch Otorhinolaryngol. 1983 Apr;237(3):201-8
6870653
Prog Neurobiol. 1999 May;58(1):1-30
10321795
Brain Res. 1998 Sep 14;805(1-2):181-90
9733963
J Neurocytol. 2000 Jul;29(7):525-37
11279367
Neuroscience. 2003;117(3):541-55
12617961
J Neurosci. 2000 Apr 15;20(8):2817-24
10751433
Acta Otolaryngol. 1981 May-Jun;91(5-6):451-6
7023177
J Neurocytol. 1973 Mar;2(1):91-103
4781457
J Neurochem. 2000 Feb;74(2):443-56
10646495